TITLE

Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis

AUTHOR(S)
Sanders, N. N.; Franckx, H.; de Boeck, K.; Hausfraete, J.; de Smedt, S. C.; Demeester, J.
PUB. DATE
November 2006
SOURCE
Thorax;Nov2006, Vol. 61 Issue 11, p962
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In the management of cystic fibrosis (CF), rhDNase-I inhalation is widely used to facilitate the removal of the highly viscous and elastic mucus (often called sputum) from the lungs. However, an important group of CF patients does not benefit from rhDNase-l treatment. A study was undertaken to elucidate the reason for the failure of rhDNase-I in these patients and to evaluate strategies to overcome this. Methods: The biochemical properties, physical properties, and degradation by rhDNase-I of sputum obtained from clinical responders and non-responders to rhDNase-I were compared, and the ability of magnesium to reactivate rhDNase-I in DNA solutions and in sputum was investigated. The effect of oral magnesium supplements on magnesium levels in the sputum of patients with CF was also examined. Results: Sputum from clinical responders was extensively degraded in vitro on incubation with rhDNase-I, while sputum from clinical non-responders was not degraded: the median decrease in sputum elasticity in the two groups was 32% and 5%, respectively. Sputum from clinical responders contained significantly higher concentrations of magnesium than sputum from non-responders (2.0 mM v 1.3 mM; p=0.020). Sputum that could not be degraded by rhDNase-I became degradable after preincubation with magnesium. The effect of magnesium on rhDNase-I activity was mediated through actin. Oral intake of magnesium enhanced the magnesium concentration in the sputum of CF patients. Conclusion: Increasing the magnesium concentration in sputum by, for example, oral magnesium supplements may be a promising new strategy to overcome the failure of rhDNase-I in patients with CF.
ACCESSION #
23259075

 

Related Articles

  • Prolastin aerosol therapy and sputum taurine in cystic fibrois. Cantin, André M.; Berthiaume, Yves; Cloutier, Diane; Martel, Marc // Clinical & Investigative Medicine;Aug2006, Vol. 29 Issue 4, p201 

    The article discusses the effects of Prolastin aerosol therapy on airway inflammation in cystic fibrosis. Prolastin is a therapeutic preparation of alpha-1 proteinase inhibitor, a neutrophil elastase inhibitor. It also presents a conclusion that aerosol therapy with Prolastin in patients with...

  • The Presence of Mucoid Pseudomonas Is Not Pathognomonic for Cystic Fibrosis. Hart, Meeghan; Borowitz, Drucy // Clinical Pediatrics;Apr2004, Vol. 43 Issue 3, p279 

    Reveals the case of a teenager who had sputum cultures positive for mucoid Pseudomonas who did not have cystic fibrosis. Presenting signs and symptoms; Past medical history; Pathogenesis; Diagnosis; Treatment; Outcome.

  • Sputum Biomarkers May Correlate With Lung Function in Cystic Fibrosis.  // Pulmonary Reviews;May2007, Vol. 12 Issue 5, p31 

    The article discusses research being done on sputum biomarkers. It references a study by Nicole Mayer-Hamblett et al in the April 15, 2007 issue of the "American Journal of Respiratory and Critical Care Medicine." Study findings suggest that sputum biomarkers may be correlates of disease...

  • Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Martin, Lois; Reid, David; Sharples, Katrina; Lamont, Iain // BioMetals;Dec2011, Vol. 24 Issue 6, p1059 

    The lungs of patients with cystic fibrosis become chronically infected with the bacterium Pseudomonas aeruginosa, which heralds progressive lung damage and a decline in health. Iron is a crucial micronutrient for bacteria and its acquisition is a key factor in infection. P. aeruginosa can...

  • Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis. Le Gall, Florence; Le Berre, Rozenn; Rosec, Sylvain; Hardy, Jeanne; Gouriou, Stéphanie; Boisramé-Gastrin, Sylvie; Vallet, Sophie; Rault, Gilles; Payan, Christopher; Héry-Arnaud, Geneviève // BMC Microbiology;2013, Vol. 13 Issue 1, p1 

    Background: The lung of patients with cystic fibrosis (CF) is particularly sensitive to Pseudomonas aeruginosa. This bacterium plays an important role in the poor outcome of CF patients. During the disease progress, first acquisition of P. aeruginosa is the key-step in the management of CF...

  • Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 3, p76 

    The article discusses research being done on the detection of bacteria in sputum from patients with cystic fibrosis (CF). It references a study by M. M. Tunney et al which appeared in a 2008 issue of the "American Journal of Respiratory and Critical Care Medicine." Results showed that chronic...

  • Mucus, Phlegm, and Sputum in Cystic Fibrosis. Rubin, Bruce K. // Respiratory Care;Jun2009, Vol. 54 Issue 6, p726 

    Although some clinicians still believe that cystic fibrosis (CF) lung disease is largely due to hypersecretion of very viscous mucus, it has never been demonstrated that there is mucus hypersecretion in CF and it is clear that there is almost no intact mucin (the principal polymeric component of...

  • carbocisteine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p142 

    An encyclopedia entry for "carbocisteine" is presented. It refers to a type of mucolytic drug used for the reduction of sputum's thickness, enabling people to cough easier. Carbocisteine can also be utilized as part of the treatment for chronic obstructive pulmonary disease and cystic fibrosis.

  • postural drainage. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p621 

    An encyclopedia entry for "postural drainage" is presented. People with cystic fibrosis and bronchiectasis can be treated by applying postural drainage, a technique clearing the lungs of sputum or other secretions, which results to better respiration. The person should lie on his or her front or...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics